Skip to main content
. 2021 Nov 18;43(5):3211–3221. doi: 10.1007/s10072-021-05723-z

Table 3.

Changes in cognitive function/behaviour and quality of life at treatment end (assessment performed at week 25) and end of follow-up in the evaluable population

Parameter Baseline (n = 13) Week 25 (n = 11) Week 48 (n = 10)
Change from baseline p value Change from baseline p value
ALS-CBS
  Behaviour status score, median (IQR) 41.0 (38.0, 42.0) 0.0 (− 3.0, 2.0) 0.7031  − 1.0 (− 6.0, 1.0) 0.2158
  Current symptom status score, median (IQR) 3.0 (2.0, 4.0) 0.0 (− 1.0, 1.0) 0.7560 0.0 (− 1.0, 1.0) 0.8281
  Cognitive screening score, median (IQR) 17.0 (16.0, 18.0) 0.0 (− 2.0, 1.0) 0.8897  − 1.0 (− 3.0, 2.0) 0.3635
ALSAQ-40
  Physical mobility, median (IQR) 20.0 (12.5, 70.0) 10.0 (0.0, 20.0) 0.0391 32.5 (7.5, 50.0) 0.0015
  Independence, median (IQR) 37.5 (20.0, 67.5) 12.5 (− 2.5, 45.0) 0.0413 25.0 (7.5, 45.0) 0.0048
  Eating/drinking, median (IQR) 0.0 (0.0, 16.7) 0.0 (0.0, 25.0) 0.0625 8.3 (0.0, 58.3) 0.0313
  Communication, median (IQR) 42.9 (0.0, 57.1) 0.0 (0.0, 28.6) 0.1250 0.0 (0.0, 35.7) 0.0625
  Emotional functioning, median (IQR) 25.0 (20.0, 32.5) 5.0 (− 2.5, 22.5) 0.0617 7.5 (0.0, 20.0) 0.0767

p-values in bold stands for p < 0.05

ALSAQ-40, Amyotrophic Lateral Sclerosis Assessment Questionnaire 40; ALS-CBS, Amyotrophic Lateral Sclerosis-Cognitive Behavioral Screen; IQR, interquartile range